Chloroquine (and a derivative, hydroxychloroquine) has been used for years in the treatment of malaria. The drug is also known to block the entry of many viruses into cells. A small clinical trial has revealed it to be effective in reducing viral loads in COVID-19 patients.
By David Tuller, DrPh Like many or most, I don€™t know what I€™m supposed to be doing right now. I am €œsheltering at home€ in San Francisco, following the news, making way too many cups of coffee, chatting much more on the phone than usual, checking in with my 90-year-old mom in Manhattan, watching movies …
by Helen Stillwell Helen is a research associate in David Hafler€™s immunobiology lab at Yale University; previously, she worked on poxviruses at Tonix Pharmaceuticals, and she plans to apply to PhD programs in virology this year. Is there a vaccine for SARS-CoV-2? The internet is awash with articles and posts seeking to shed light on …
By David Tuller, DrPH And here’s yet another study from Professor Trudie Chalder and colleagues at King’s College London, this time tackling fatigue in people with HIV, an often debilitating problem. The study, “A Biopsychosocial Approach to HIV Fatigue: A Cross-Sectional and Prospective Analysis to Identify Key Modifiable Factors”, was published online last month by …
Trial By Error: New Biopsychosocial Study of Fatigue in HIV Patients Read More »
Health experts say it€™s not a question of whether SARS-CoV-2 will spread within the U.S., but when. A CDC official said yesterday, €œWe are asking the American public to prepare for the expectation that this might be bad.€ What exactly does that mean?
By David Tuller, DrPH When I was in Australia two years ago–wow, can’t believe it’s been that long!–I spent some time with Dr Mark Guthridge, an associate professor of biomedical science at Deakin University in Melbourne. Several years ago, after a bout of mononucleosis/glandular fever, he developed myalgic encephalomyelitis, which in Australia even patients and …
Trial By Error: An Australian Radio Interview with Melbourne’s Dr Mark Guthridge Read More »
